$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
苯达莫司汀和美罗华使用间隔时间多长
2025-10-19 11:44:20
Check Details
苯达莫司汀联合利妥昔单抗的效果怎么样
2025-10-19 11:44:20
Check Details
苯达莫司汀联合利妥昔单抗治疗淋巴瘤效果
2025-10-19 11:44:20
Check Details
利妥昔单抗(美罗华)说明书
2025-10-19 11:44:20
Check Details
利妥昔单抗治疗非霍奇金淋巴瘤的效果
2025-10-19 11:44:20
Check Details
ROR1靶向药在MCL和DLBCL的首次人体研究中产生临床活性
2025-10-19 11:44:20
Check Details
所有年龄段患者均可使用Selinexor治疗R/R DLBCL
2025-10-19 11:44:20
Check Details
Parsaclisib对未接触过BTK的R/R MCL患者的ORR改善显著
2025-10-19 11:44:20
Check Details
瑞士罗氏利妥昔单抗怎么使用?
2025-10-19 11:44:20
Check Details
瑞士罗氏利妥昔单抗医保可以报销吗?
2025-10-19 11:44:20
Check Details
瑞士罗氏利妥昔单抗哪里有卖?
2025-10-19 11:44:20
Check Details
瑞士罗氏利妥昔单抗对淋巴瘤有多大的疗效?
2025-10-19 11:44:20
Check Details
1
2
...
1229
1230
1231
1232
1233
1234
1235
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
2
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
3
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
4
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
5
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
6
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
7
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
12
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).